⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
From Ambrx to Oncolytics: Why Jared Kelly Believes the Market May Be Missing the Bigger Oncology Story
accessnewswire.com
AMRX
ONCY
Knox Systems and RapidFort Join Forces to Defend Against Mythos-Generated CVE Threats and Fast-Track FedRAMP Compliance
businesswire.com
ADBE
AMRX
Form 8-K
sec.gov
AMRX
Form 8-K
sec.gov
AMRX
Amneal Reports First Quarter 2026 Financial Results
globenewswire.com
AMRX
AMERX ADDS EQUITY RESEARCH FOR INSTITUTIONAL CLIENTS
prnewswire.com
AMRX
No Waitlists, No Pharmacies: AM Rx Brings Same-Day GLP-1 Weight Loss Consultations to Patients Nationwide
accessnewswire.com
AMRX
Form 8-K
sec.gov
AMRX
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader
businesswire.com
AMRX
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
globenewswire.com
AMRX